Literature DB >> 16943215

[Tc]-99m thyroid scintigraphy in congenital hypothyroidism screening program.

R Iranpour1, M Hashemipour, M Amini, S M Talaei, R Kelishadi, S Hovsepian, S Haghighi, Kh Khatibi.   

Abstract

The aetiology of congenital hypothyroidism (CH) may be important in determining disease severity, outcome and treatment schedules because athyroid patients need higher treatment doses and close monitoring particularly early in life. The aim of this study was to evaluate thyroid scintigraphy (TS) findings in infants with CH and to determine the relationship of serum TSH and T4 values with thyroid agenesia, in an attempt to identify factors that may detect thyroid agenesia before treatment. Since August 2002 to April 2005, screening program for CH was carried out in the Isfahan University of Medical Sciences and Health Services, Isfahan, Iran. Screening was performed by measuring both the serums T4 and TSH concentration at day 3-7 of birth. Full-term newborns were recalled based on a serum TSH >20 mIU/l or serum T4 < 6.5 microg/dl and premature newborns based on T4 level by weight and TSH level by age. After repeating the laboratory test and clinical evaluation, Tc-99m TS was recommended for all infants with suspected CH before thyroxin replacement therapy. On the basis of Tc-99m TS, the thyroid gland was classified as normal scan, ectopic, goiter and athyrosis. TS results were compared with serum T4 and TSH levels. Of 93 381 newborns screened over a period of nearly 3 years, 262 neonates were found to have CH. The overall incidence of CH was 1 : 357 live births with a female/male ratio (F/M) of 1.4/1. Thyroid scan was performed on 116 (54%) of the infants with CH; of them, 33 cases (28.4%) were athyrotic (F/M = 0.8/1) while seven infants (6%) had ectopic thyroid (F/M = 1.3/1) and 76 cases (65.6%) had a normal thyroid scan (F/M = 1.5/1). Infants with the absence of thyroid in TS had significantly higher TSH value in comparison with those with ectopic or normal TS (116.3 +/- 109.64 vs. 108.10 +/- 62.92 or 55.35 +/- 48.26 mIU/l, respectively, P < 0.0001). Although not statistically different, the mean T4 level was higher in normal TS group than in ectopic and athyrotic groups (8.03 +/- 3.48 vs. 6.36 +/- 5.57 or 5.04 +/- 3 microg/dl, respectively, P = 0.09). We conclude that Tc-99m TS is a useful diagnostic tool for the initial investigation of suspected CH and considering the correlation of TS results with blood TSH levels, proper management and close monitoring of hypothyroid infants with severe hormonal alterations is necessary for the detection of thyroid agenesia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943215     DOI: 10.1093/tropej/fml038

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  4 in total

Review 1.  Congenital Hypothyroidism and the Deleterious Effects on Auditory Function and Language Skills: A Narrative Review.

Authors:  Caio Leônidas Oliveira Andrade; Crésio de Aragão Dantas Alves; Helton Estrela Ramos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-10       Impact factor: 5.555

2.  The role of ultrasonography in primary congenital hypothyroidism.

Authors:  Mahin Hashemipour; Noushin Rostampour; Peyman Nasry; Silva Hovsepian; Reza Basiratnia; Ali Hekmatnia; Amir Hossein Shahkarami; Ali Mehrabi; Rezvane Hadian; Massoud Amini
Journal:  J Res Med Sci       Date:  2011-09       Impact factor: 1.852

3.  Intelligence quotient in children with congenital hypothyroidism: The effect of diagnostic and treatment variables.

Authors:  Seyed Badredin Najmi; Mahin Hashemipour; Mohammad Reza Maracy; Silva Hovsepian; Mahmood Ghasemi
Journal:  J Res Med Sci       Date:  2013-05       Impact factor: 1.852

4.  Thyroid peroxidase gene mutation in patients with congenital hypothyroidism in isfahan, iran.

Authors:  Mahin Hashemipour; Fahimeh Soheilipour; Sakineh Karimizare; Hossein Khanahmad; Morteza Karimipour; Sepideh Aminzadeh; Leila Kokabee; Massoud Amini; Silva Hovsepian; Rezvaneh Hadian
Journal:  Int J Endocrinol       Date:  2012-08-02       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.